The Business Times
business-time-50

Global pharma firms interested in local startup's new glaucoma treatment

google-preferred-sourceAdd BT as a preferred source
Published Tue, Dec 9, 2014 · 09:50 PM

    Singapore

    "FIRST you have my interest, now you have my attention."

    And that is what local biotech startup Peregrine Ophthalmic managed to do, in the words of associate professor Tina Wong, who was describing how a new glaucoma drug delivery solution developed by her 15-month-old startup has attracted inquiries from the world's top five pharmaceutical companies.

    TRENDING NOW

    Vincent Tan, founder of Berjaya Group, has reduced his holdings in multiple companies within the group.

    Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan

    The S$1 billion wellness attraction in Marina South is slated to open in 2030.

    Beyond beaches or Bali: Singapore’s push for urban wellness tourism

    The onset of El Nino is also seen as a tailwind, as average crude palm oil prices have historically surged during the weather event.

    Palm oil stocks set to surge as Indonesia said to be scaling back export overhaul: analysts

    Practices that once helped small businesses in Vietnam stay flexible and competitive in a low-margin economy are increasingly becoming formal business risks.

    Can Vietnam’s small-business backbone survive a compliance squeeze – all at once?

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More